These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8308188)

  • 1. Is there a prevention and treatment strategy for macular degeneration?
    Richer SP
    J Am Optom Assoc; 1993 Dec; 64(12):838-50. PubMed ID: 8308188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional antioxidants and age-related cataract and maculopathy.
    Chiu CJ; Taylor A
    Exp Eye Res; 2007 Feb; 84(2):229-45. PubMed ID: 16879819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related maculopathy and the impact of blue light hazard.
    Algvere PV; Marshall J; Seregard S
    Acta Ophthalmol Scand; 2006 Feb; 84(1):4-15. PubMed ID: 16445433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ideal ocular nutritional supplement?
    Bartlett H; Eperjesi F
    Ophthalmic Physiol Opt; 2004 Jul; 24(4):339-49. PubMed ID: 15228513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nutrition and age-related macular degeneration].
    Desmettre T; Lecerf JM; Souied EH
    J Fr Ophtalmol; 2004 Nov; 27(9 Pt 2):3S38-56. PubMed ID: 15602406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free radicals and antioxidant supplementation: a review of their roles in age-related macular degeneration.
    van der Hagen AM; Yolton DP; Kaminski MS; Yolton RL
    J Am Optom Assoc; 1993 Dec; 64(12):871-8. PubMed ID: 8308191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intake of zinc and antioxidant micronutrients and early age-related maculopathy lesions.
    Morris MS; Jacques PF; Chylack LT; Hankinson SE; Willett WC; Hubbard LD; Taylor A
    Ophthalmic Epidemiol; 2007; 14(5):288-98. PubMed ID: 17994438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of macular degeneration, according to Bangerter.
    Teichmann KD
    Eur J Med Res; 1997 Oct; 2(10):445-54. PubMed ID: 9348273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protocol for the evaluation and treatment of atrophic age-related macular degeneration.
    Richer S
    J Am Optom Assoc; 1999 Jan; 70(1):13-23. PubMed ID: 10457678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of Preferential Hyperacuity Perimeter (PHP) test and Amsler grid test in the diagnosis of different stages of age-related macular degeneration].
    Kampmeier J; Zorn MM; Lang GK; Botros YT; Lang GE
    Klin Monbl Augenheilkd; 2006 Sep; 223(9):752-6. PubMed ID: 16986086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do blue light filters confer protection against age-related macular degeneration?
    Margrain TH; Boulton M; Marshall J; Sliney DH
    Prog Retin Eye Res; 2004 Sep; 23(5):523-31. PubMed ID: 15302349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter ophthalmic and nutritional age-related macular degeneration study--part 2: antioxidant intervention and conclusions.
    Richer S
    J Am Optom Assoc; 1996 Jan; 67(1):30-49. PubMed ID: 8825017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular degeneration: recent advances and therapeutic opportunities.
    Rattner A; Nathans J
    Nat Rev Neurosci; 2006 Nov; 7(11):860-72. PubMed ID: 17033682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients.
    Bourre JM
    J Nutr Health Aging; 2006; 10(5):377-85. PubMed ID: 17066209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter ophthalmic and nutritional age-related macular degeneration study--part 1: design, subjects and procedures. Age-related Macular Degeneration Study Group.
    J Am Optom Assoc; 1996 Jan; 67(1):12-29. PubMed ID: 8825016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macular pigment and age-related macular degeneration. Clinical implications].
    Haddad WM; Souied E; Coscas G; Soubrane G
    Bull Soc Belge Ophtalmol; 2006; (301):15-22. PubMed ID: 17552428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathomechanisms for aging of retinal pigment epithelium (RPE) and prophylactic therapy options in regard to AMD].
    Schütt F; Kopitz J; Yu A; Welge-Lüssen U
    Klin Monbl Augenheilkd; 2008 Jun; 225(6):548-54. PubMed ID: 18516775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of dietary antioxidant levels and supplementation with ICAPS-Plus and Ocuvite.
    Kaminski MS; Yolton DP; Jordan WT; Yolton RL
    J Am Optom Assoc; 1993 Dec; 64(12):862-70. PubMed ID: 8308190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lutein and eye health--current state of discussion].
    Hahn A; Mang B
    Med Monatsschr Pharm; 2008 Aug; 31(8):299-308. PubMed ID: 18754570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.